3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
1
Liver Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dexamethasone
43
Lenalidomide
26
daratumumab
23
Bortezomib
23
pomalidomide
22
Cyclophosphamide
16
Specimen Handling
14
Biopsy
14
carfilzomib
13
Magnetic Resonance Spectroscopy
11
talquetamab
10
iberdomide
9
fludarabine
9
Calcium Dobesilate
9
isatuximab
8
Melphalan
8
belantamab mafodotin
7
selinexor
5
fludarabine phosphate
5
X-Rays
5
elotuzumab
4
Whole-Body Irradiation
4
Nuclear Medicine Department, Hospital
4
trametinib
3
tocilizumab
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
dabrafenib
3
auricularum
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
tremelimumab
×
30 days
×
Clear all
No trials found.